Eli Lilly expands partnership with Innovent to develop oncology, immunology drugs
Source: SeekingAlpha
2026-02-08 10:33:49 ET
More on Eli Lilly, Innovent Biologics
- Eli Lilly: Positives Outweigh The Concerns
- Eli Lilly and Company 2025 Q4 - Results - Earnings Call Presentation
- Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript
- President Trump unveils TrumpRx website for low-cost prescription drugs
- Eli Lilly, Novo down as Hims to offer cheaper weight-loss pill
Read the full article on Seeking Alpha
For further details see:
Eli Lilly expands partnership with Innovent to develop oncology, immunology drugs
Innovent Biologics Inc
NASDAQ: IVBXF
IVBXF Trading
-1.19% G/L:
$9.95 Last:
8,095 Volume:
$10 Open:
